One of our recent evaluations looked at an innovative method for labelling cancer cells (see the story here). In the original paper, researchers at Massachusetts General Hospital developed a process to specifically tag cancer cells by using chemically modified antibodies to home in on cancer cells and then cycloaddition to dye the antibody, making the…
My spies over at BioMed Central brought my attention to an Opinion piece in J. Biol by Arthur Lander at UCI, published on Monday. So newsworthy, they press-released it just in time for Stem Cell Awareness Day, which was yesterday. Oh well—we at f1000 have never claimed to bring you the latest research; rather just the best, no matter where it’s…
It’s all in the mind, you know. Blame it on my lack of a classical education, but it was only a couple of years ago I realized that the word ‘hysteria’ is a feminist issue. It comes via the Greek for ‘uterus’, hence υστερία. The ancients believed that psychological-based problems (as opposed to physical ailments) only…
Our good friends at The Scientist named those who will receive the National Medal of Science in the US next month and we are happy to report one of our colleagues made the grade. Biochemist JoAnne Stubbe from the Massachusetts Institute of Technology, who The Scientist recently profiled, is being honored for her work on…
Clive Cookson over at the Financial Times reports on Wednesday night’s tête–à-tête between Lord Drayson, the UK’s Science Minister, and writer/broadcaster/medical doctor Ben Goldacre. Goldacre is behind badscience.net and is somewhat outspoken in his opinions. I didn’t sign up to see the debate, seeing as I’d been invited to a movie: which I’m convinced was more…
We had a lot of welcome interest this morning on a press release, from the expected (New Scientist, LiveScience.com) to the unusual (Die Welt, Sueddeutsche Zeitung), which showed once again that a sexy title and the combination of money, pain and relationships still make attractive reading. What we always hope is that the message doesn’t…
As a follow-up to yesterday’s tweet about the Sense About Science’s sensibly titled Peer Review Survey, a few thoughts. Out of the press reports on the Elsevier-funded study I’ve scanned though, a common phrase seemed to “no one has come up with a better method than peer reviewing, so we’re stuck with it”. My colleague…
…what dreams may come When we have shuffled off this mortal coil, Must give us pause Thomson, in a commentary in the Journal of the American Medical Association, reckon there ain’t nowt wrong with the Journal Impact Factor: The impact factor has had success and utility as a journal metric due to its concentration on…
As mentioned, I’m the new PR Manager at f1000 and will working on some exciting promotions for the website and the company in general. To give some background, I shifted over from Australia last August and did a short stint in the wilds of local council in Dagenham before a much more interesting senior press…
